TrialJAMA network open2022

Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.

John Cafardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.